These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Sudden cardiac death and implantable cardioverter-defibrillators. Turakhia MP Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520 [TBL] [Abstract][Full Text] [Related]
25. Application of microvolt T-wave alternans testing in scheduling implantable cardioverter-defibrillator placement for the primary prevention of sudden cardiac death in patients with left ventricular dysfunction. Daniłowicz-Szymanowicz L; Suchecka J; Zagożdżon P; Szwoch M; Kempa M; Raczak G Kardiol Pol; 2015; 73(6):429-36. PubMed ID: 25371309 [TBL] [Abstract][Full Text] [Related]
26. Description of a nursing intervention program after an implantable cardioverter defibrillator. Dougherty CM; Pyper GP; Frasz HA Heart Lung; 2004; 33(3):183-90. PubMed ID: 15136779 [TBL] [Abstract][Full Text] [Related]
27. Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy. Choi GR; Porter CB; Ackerman MJ Pediatr Clin North Am; 2004 Oct; 51(5):1289-303. PubMed ID: 15331285 [TBL] [Abstract][Full Text] [Related]
28. Patient plus partner trial: A randomized controlled trial of 2 interventions to improve outcomes after an initial implantable cardioverter-defibrillator. Dougherty CM; Thompson EA; Kudenchuk PJ Heart Rhythm; 2019 Mar; 16(3):453-459. PubMed ID: 30340060 [TBL] [Abstract][Full Text] [Related]
29. [Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy]. Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J Pol Merkur Lekarski; 2017 Feb; 42(248):65-70. PubMed ID: 28258679 [TBL] [Abstract][Full Text] [Related]
30. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. Ingles J; Sarina T; Kasparian N; Semsarian C Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269 [TBL] [Abstract][Full Text] [Related]
31. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003. Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520 [TBL] [Abstract][Full Text] [Related]
32. The implantable cardioverter-defibrillator: does everybody need one? Raj SR; Sheldon RS Prog Cardiovasc Dis; 2001; 44(3):169-94. PubMed ID: 11727276 [TBL] [Abstract][Full Text] [Related]
33. Living with an implantable cardioverter defibrillator: The patients' experience. Humphreys NK; Lowe R; Rance J; Bennett PD Heart Lung; 2016; 45(1):34-40. PubMed ID: 26581117 [TBL] [Abstract][Full Text] [Related]
34. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation. Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943 [TBL] [Abstract][Full Text] [Related]
35. Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD). Godemann F; Butter C; Lampe F; Linden M; Werner S; Behrens S Qual Life Res; 2004 Mar; 13(2):411-6. PubMed ID: 15085913 [TBL] [Abstract][Full Text] [Related]
36. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators. Sears SF; Conti JB Am J Cardiol; 2006 Aug; 98(4):565-7. PubMed ID: 16893718 [TBL] [Abstract][Full Text] [Related]
37. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation. Healy CA; Carrillo RG Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113 [TBL] [Abstract][Full Text] [Related]
38. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator. Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055 [TBL] [Abstract][Full Text] [Related]
39. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon. Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624 [TBL] [Abstract][Full Text] [Related]
40. Help seeking in a support group for recipients of implantable cardioverter defibrillators and their support persons. Dickerson SS; Posluszny M; Kennedy MC Heart Lung; 2000; 29(2):87-96. PubMed ID: 10739484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]